Since its clinical introduction in 2008, sugammadex has demonstrated a high degree of
safety and superior effectiveness compared to neostigmine when used to antagonize …

Women with neurologic conditions present a challenge during pregnancy and in the
peripartum period. Given the low prevalence of these diseases during pregnancy, most …

Background Sugammadex is a modified gamma-cyclodextrin that acts by selectively
encapsulating free amino-steroidal neuromuscular relaxants. Several case reports have …

BACKGROUND: Rocuronium for cesarean delivery under general anesthesia is an
alternative to succinylcholine for rapid-sequence induction of anesthesia because of the …

Providing anesthesia to patients with myotonic dystrophy (DM) can be very challenging due
to the multisystemic effects of the disease and extreme sensitivity of these patients to …

Introduction: Sugammadex is the first clinical representative of a class of drugs called
steroidal muscle relaxant encapsulators. Due to its 1: 1 binding of rocuronium or …

Since its launch in 2008, sugammadex has been considered one of the most significant
developments in anaesthesia-related pharmacology. With almost 500 sugammadex-related …

Objective: To describe the main clinical aspects of muscular dystrophies, their etiology,
anesthetic implications, and the major complications that may occur during the perioperative …

Abstract Purpose of Review The main objective of this review article is to discuss the
prevalence, utilization, and outcomes associated with advanced heart failure therapies …

Sugammadex offers significant advantages over the current anticholinesterase reversal
drugs. Sugammadex used has been approved for the United Stated and for Canada since …